There are several types of liver cancer in adults, and the two most common types are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). HCC is the most common form of liver cancer among adults, and ICC is a type of liver cancer that occurs in parts of the bile ducts within the liver. Rising advancements in three-dimensional reconstruction image processing technology transformed liver two-dimensional image data into three-dimensional stereoscopic models, and three-dimensional reconstructed images can be restored to real physical models by 3D printing technology.
Further, intuitively exhibiting comprehensive information, such as variations of intrahepatic blood arteries, in greater accuracy and detail is now possible with computer-generated 3D visualization or 3D printed modeling. Moreover, liver volume computation to surgical navigation is vastly improved due to 3D visualization or 3D printed modeling, which allowed for detailed classification of hepatic vessels and liver segmentation, known as Fang’s segmentation, used in diagnosing and treating primary liver cancer.
Furthermore, due to the rapid development in computer science in the last several decades, especially in artificial intelligence (AI), concepts, such as machine learning, deep learning, and big data have been applied in many aspects. Deep learning based on artificial neural networks expands the scope of artificial intelligence in the medical field. The research of Radiomics of deep learning is one of the most popular research fields at present. The study of liver diseases by radiomics will contribute to the early diagnosis and treatment of liver diseases and improve survival and cure rates of liver diseases. Thus, the rising emergence of new technologies is expected to boost the market during the forecast period.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America Liver cancer diagnostics market at a substantial CAGR during the forecast period.
South America Liver Cancer Diagnostics Market Segmentation
The South America liver cancer diagnostics market is analyzed on the basis of type, end user, and country. Based on type, the market is segmented into laboratory tests, imaging, endoscopy, biopsy, and others. In 2021, the laboratory tests segment held the largest share of the market, and the imaging segment is expected to register a higher CAGR during the forecast period.
Based on laboratory tests, the market is segmented into blood tests and biomarkers. In 2021, the blood tests segment held a larger market share, and the same segment is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. In 2021, the hospitals and diagnostic laboratories segment held the largest share of the market, and the same segment is expected to register a higher CAGR during the forecast period.
Based on country, the South America liver cancer diagnostics market is segmented into Brazil, Argentina, and the Rest of SAM. In 2021, Brazil held the largest market share, and Argentina is expected to grow at the fastest CAGR during the forecast period.
Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; and Perspectum are the leading companies in the South America liver cancer diagnostics market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 626.52 Million |
| Market Size by 2028 | US$ 1,025.70 Million |
| CAGR (2021 - 2028) | 7.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
The South America Liver Cancer Diagnostics Market is valued at US$ 626.52 Million in 2021, it is projected to reach US$ 1,025.70 Million by 2028.
As per our report South America Liver Cancer Diagnostics Market, the market size is valued at US$ 626.52 Million in 2021, projecting it to reach US$ 1,025.70 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The South America Liver Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Liver Cancer Diagnostics Market report:
The South America Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South America Liver Cancer Diagnostics Market
